Skip to main content

Table 3 Utilization and cost of diabetes testing supplies by Type of Diabetes and Treatment, Saskatchewan 2001

From: Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001

 

Number of Cases

Number (%) of Subjects with ≥ 1 record for testing supplies

Average (SD) Number of Records

Average (SD) DP share (Can$)

Average (SD) Patient Share (Can$)

Average (SD)A, BTotal (Can$)

Type 1

4005

3143 (78.5)

5.8 (6.4)

231.71 (408.53)A

240.60 (343.81)A

472.31 (560.75)A

(% of Total)

(9.6%)

  

(49.1%)

(50.9%)

 

Type 2

      

   No medication

14157

3169 (22.4%)

0.5 (1.5)

11.78 (62.14)B

23.69 (72.61)B

35.47 (107.22)B

(% of Type 2)

(37.6%)

  

(33.2%)

(66.8%)

 

   Oral anti-diabetic agent only

18910

11814 (62.5)

2.0 (2.6)

57.78 (132.42)

73.42 (110.65)

131.21 (189.78)

(% of Type 2)

(50.3%)

  

(44.0%)

(56.0%)

 

   Insulin only

2212

1751 (79.2)

4.6 (5.0)

194.53 (296.40)

153.33 (233.26)

347.86 (409.39)

(% of Type 2)

(5.9%)

  

(55.9%)

(44.1%)

 

   Insulin and oral anti-diabetic agent

2346

2037 (86.8)

4.9 (4.4)

220.08 (286.55)

148.48 (187.50)

368.56 (362.67)

(% of Type 2)

(6.2%)

  

(59.7%)

(40.3%)

 

Type 2 Total

37625

18771 (49.9)

1.8 (2.9)

58.63 (155.18)A

64.09 (122.86)A

122.72 (233.88)A

(% of Total)

(90.4%)

  

(47.8%)

(52.2%)

 
  1. A p < 0.001 between type 1 and type 2 diabetes using the Kruskal Wallis Test
  2. B p < 0.001 between treatment groups within type 2 diabetes (i.e. no medication, oral anti-diabetic agent only, insulin only, insulin and oral anti-diabetic agent) using the Kruskal Wallis Test